No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 6, 1999, Pages 964-967

  Van Vugt, M ^a,b   Ezzet, F ^c   Nosten, F ^a,d   Gathmann, I ^c   Wilairatana, P ^e   Looareesuwan, S ^e   White, N J ^d,e  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NOVARTIS PHARMA AG   (Switzerland)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTESUNATE; BENFLUMETOL; MEFLOQUINE;

ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILD; DRUG BLOOD LEVEL; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; PRESCHOOL CHILD; SCHOOL CHILD;

ARTESUNATE; PROTOZOA;

EID: 0033386669     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.964     Document Type: Article

References (17)

1. White NJ, Looareesuwan S, Warrell DA, 1983. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol 5: 173-175.
2. Nosten F, ter Kuile FO, Luxemburger C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, White NJ, 1993. Cardiac effects of antimalarial treatment with halofantrine. Lancet 341: 1054-1056.
3. Gundersen SG, Rostrup M, von der Lippe E, Platou ES, Myrvang B, Edwards G, 1997. Halofantrine-associated ventricular fibrillation in a young woman with no predisposing QTc prolongation. Scand J Infect Dis 29: 207-208.
4. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras J M, Levine BS, Heiffer MH, Schuster BG, 1994. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 51: 251-259.
5. Hien TT, Day NPJ, Phu NH, Mai NT, Chau TT, Loc PP, Sinh DX, Chuong LV, Vinh H, Waller D, Peto TEA, White NJ, 1996. Controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335: 76-83.
6. Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, ter Kuile F, Kham A, Chongsuphajaisiddhi T, White NJ, Nosten F, 1999. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 60: 547-555.
7. van Vugt M, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, Luxemburger C, White NJ, Nosten F, Looareesuwan S, 1999. Efficacy of six doses of artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg 60: 936-942.
8. van Vugt M, Gathmann I, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Mull R, Brockman A, White NJ, Nosten F, 1999. A randomized comparison of the six dose artemether-lumefantrine regimen with artesunate-mefloquine in the treatment of multi-drug resistant malaria. Trans R Soc Trop Med Hyg: (in press).
9. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Pa Eh J, Chongsuphajaisiddhi T, White NJ, 1994. Treatment of multi drug resistant Plasmodium falciparum malaria with 3 day artesunate-mefloquine combination. J Infect Dis 170: 971-977.
10. Zeng MY, Lu ZL, Yang S-C, Zhang M, Liao J, Liu S-L, Teng XH, 1996. Determination of benflumetol in human plasma by reverse-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr 681: 299-306.
11. White NJ, van Vugt M, Ezzet F, 1999. Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet: (in press).
12. Savelieva I, Yi G, Guo X, Hnatkova K, Malik M, 1998. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion. Am J Cardiol 81: 471-477.
13. Matson PA, Luby SP, Redd SC, Rolka HR, Meriwether RA, 1996. Cardiac effects of standard-dose halofantrine therapy. Am J Trop Med Hyg 54: 229-231.
14. Touze JE, Bernard J, Keundjian A, Imbert P, Viguier A, Chaudet H, Doury JC, 1996. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Am J Trop Med Hyg 54: 225-228.
15. von Seidlein L, Jaffar S, Greenwood B, 1997. Prolongation of the QTc interval in African children treated for falciparum malaria. Am J Trop Med 56: 494-497.
16. Price R, Nosten F, White NJ, 1998. Rate correction of the QT interval (letter). Am J Trop Med Hyg 59: 503.
17. Palmer KJ, Holliday SM, Brogden RN, 1993. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45: 430-475.